戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  impairment, and depressive symptoms (2-item Patient Health Questionnaire).
2  and symptoms of depressive disorder (9-item Patient Health Questionnaire).
3 erformance Battery) and depressive symptoms (Patient Health Questionnaire).
4 ere screened for depression using the 9-item Patient Health Questionnaire.
5       Major depression was assessed with the Patient Health Questionnaire.
6  Checklist; depression was assessed with the Patient Health Questionnaire.
7 nal neurological symptoms as measured by the Patient Health Questionnaire-15 and the Screening for So
8 y and Depression Scale questionnaire and the Patient Health Questionnaire-15.
9            The Primary Care PTSD Screen, the Patient Health Questionnaire-2 (modified), the suicidal
10  screen for positive Coping Screen patients (Patient Health Questionnaire-2 [PHQ-2], GAD-2, and an it
11 mplate comprising five questions (a two-item Patient Health Questionnaire-2 for depression, a two-ite
12 5% CI, 1.003 to 1.032; P < .017), and higher Patient Health Questionnaire-4 depression symptoms (OR,
13 sessment System) and psychological distress (Patient Health Questionnaire-4).
14                                          The Patient Health Questionnaire 8, International Classifica
15 training but were not hired) who completed a Patient Health Questionnaire-8 and four-item Primary Car
16 rformance Battery), and depressive symptoms (Patient Health Questionnaire-8).
17 m Health Survey, the Rose Dyspnea Scale, the Patient Health Questionnaire-8, and the EQ-5D.
18 aged 18-65 years scoring more than 14 on the Patient Health Questionnaire 9 (PHQ-9) indicating modera
19 ion used; stratified by depression severity [Patient Health Questionnaire 9 (PHQ-9) score of <19 vs >
20  to have access to the internet and email, a Patient Health Questionnaire 9 (PHQ-9) score of at least
21 oderately severe to severe depression on the Patient Health Questionnaire 9 (PHQ-9) were randomised t
22 iable was a depression score measured by the Patient Health Questionnaire 9 (PHQ-9), a self-report qu
23         Nonquitters worsened slightly on the Patient Health Questionnaire 9 relative to quitters (dif
24 r and at least moderate depression severity (Patient Health Questionnaire 9 score > or = 10).
25 was no evidence of an intervention effect on Patient Health Questionnaire 9 score, suicidal behaviour
26 etes Mellitus, Diabetes Self-Care Inventory, Patient Health Questionnaire 9, and National Eye Institu
27 4-item Hamilton Rating Scale for Depression, Patient Health Questionnaire 9, and the Center for Epide
28 atedly assessed using the PTSD Checklist and Patient Health Questionnaire 9, respectively, to determi
29 years) who screened positive for depression (Patient Health Questionnaire 9-item [PHQ-9] score >/=10)
30 the Veterans RAND 12-Item Health Survey, the Patient Health Questionnaire 9-item depression scale (PH
31 ssessed at baseline and at 12 weeks with the Patient Health Questionnaire-9 (PHQ-9) and was scored di
32 cularly the anxiety dimension and the use of Patient Health Questionnaire-9 (PHQ-9) as depression sev
33 ve symptoms from baseline as assessed by the Patient Health Questionnaire-9 (PHQ-9) depression scale
34 in studies of the diagnostic accuracy of the Patient Health Questionnaire-9 (PHQ-9) depression screen
35       Research coordinators administered the Patient Health Questionnaire-9 (PHQ-9) during the index
36                       Patients completed the Patient Health Questionnaire-9 (PHQ-9), which included I
37 ssion, as determined by a score >/=10 on the Patient Health Questionnaire-9 (PHQ-9).
38 Ham-D) and self-reported depression with the Patient Health Questionnaire-9 (PHQ-9).
39  322 patients without depression, defined by Patient Health Questionnaire-9 [PHQ-9] score) conducted
40 derate to severe depression according to the Patient Health Questionnaire-9 [RR, 2.3; 95% CI, 1.5 to
41 ss disorder symptoms were assessed using the Patient Health Questionnaire-9 and the Posttraumatic Str
42       Depressive symptoms were assessed with Patient Health Questionnaire-9 at baseline and during fi
43                                          The Patient Health Questionnaire-9 detected moderate to seve
44 ons Questionnaire for work outcomes, and the Patient Health Questionnaire-9 for depression.
45   The participating patients had depression (Patient Health Questionnaire-9 score > or = 10), cancer-
46 ms and probable major depression (defined as Patient Health Questionnaire-9 score >/=10).
47 ressive symptoms assessed from self-reported Patient Health Questionnaire-9 score at 13 years (n = 5
48 ssion severity (difference in mean change in Patient Health Questionnaire-9 score from baseline, -2.9
49                                The mean (SD) Patient Health Questionnaire-9 score was significantly h
50                                          The Patient Health Questionnaire-9 was used to assess depres
51                                          The Patient Health Questionnaire-9 was used to assess suicid
52 ened positive (a score of at least 10 on the Patient Health Questionnaire-9) and met criteria for maj
53 ancer Therapy-General), depressive symptoms (Patient Health Questionnaire-9), and coping (Brief COPE)
54 ine to week 24, change in depression per the Patient Health Questionnaire-9, and differences in end-o
55 ed), the suicidal ideation question from the Patient Health Questionnaire-9, and several other questi
56 S, the Hamilton Depression Rating Scale, the Patient Health Questionnaire-9, and the Quality of Life
57 es were the PTSD Checklist-Civilian Version, Patient Health Questionnaire-9, Generalised Anxiety Diso
58 major depressive disorder as measured by the Patient Health Questionnaire-9, health care utilization
59 e-15, Hospital Anxiety and Depression Scale, Patient Health Questionnaire-9, Profile of Mood States-S
60  Anxiety and Depression Scale (HADS) and the Patient Health Questionnaire-9, which also assessed suic
61   Diagnosis of major depression based on the Patient Health Questionnaire-9.
62 ts in United States and Canada completed the Patient Health Questionnaire-9.
63 improvement in depression as measured by the Patient Health Questionnaire-9.
64 : 29 +/- 25 vs. 10 +/- 22 [p < 0.001]; Delta Patient Health Questionnaire-9: -5 +/- 7 vs. -1 +/- 5 [p
65 he Hospital Anxiety and Depression Scale and Patient Health Questionnaire (adjusted mean difference,
66  Primary Care Evaluation of Mental Disorders Patient Health Questionnaire and modified CAGE questionn
67 thers were examined for depression using the Patient Health Questionnaire depression module antepartu
68 gh Postnatal Depression Scale and the 9-item Patient Health Questionnaire; elevated depression sympto
69  December 2010 and completed a 1-time 9-item Patient Health Questionnaire for depression categorized
70 ening instruments, the GAD-7 for GAD and the Patient Health Questionnaire for panic disorder, have go
71 ymptoms, defined as an elevated score on the Patient Health Questionnaire (&gt;/= 10) and/or a diagnosis
72 with scores indicative of depression (9-item Patient Health Questionnaire, &gt;/=10) showed greater cogn
73                         Data were sparse for Patient Health Questionnaire instruments.
74 y used self-rated symptom questionnaire- the Patient Health Questionnaire (PHQ 15) (plus enhanced ite
75                                          The Patient Health Questionnaire (PHQ) depression and anxiet
76 rity Index for alcohol and drug outcomes and Patient Health Questionnaire (PHQ) for depression).
77           Screening for depression using the Patient Health Questionnaire (PHQ) has been extensively
78 ecificity:0.83; 95% CI 0.72 to 0.90) and the Patient Health Questionnaire (PHQ)-9 (sensitivity: 0.86;
79  depressive symptoms were assessed using the Patient Health Questionnaire (PHQ).
80  We investigated the potential of the 2-item patient health questionnaire (PHQ-2) versus that of the
81 e primary outcome was the difference in mean Patient Health Questionnaire (PHQ-9) scores at 3 months
82 y, the score for the depression scale of the Patient Health Questionnaire (PHQ-9) was significantly h
83        Patients who scored 9 or above on the Patient Health Questionnaire (PHQ-9) were administered t
84 sed for depressive symptoms using the 9-item Patient Health Questionnaire (PHQ-9), a series of psycho
85 Neurologic Study-Lability Scale (CNS-LS) and Patient Health Questionnaire (PHQ-9), respectively) were
86 n symptoms at 6 months, as measured with the Patient Health Questionnaire (PHQ-9).
87  severity at 4-month follow-up on the 9-item Patient Health Questionnaire (PHQ-9; score range, 0-27).
88  service use, depression (measured using the Patient Health Questionnaire [PHQ]-9), and mental health
89 he Hospital Anxiety and Depression Scale and Patient Health Questionnaire, PTSD checklist, and Functi
90 1018 adults with depressive symptoms (8-item Patient Health Questionnaire score >/=10), 88% of whom w
91 mated crude prevalence of depression (9-item Patient Health Questionnaire score of >/=10) was 11.3% (
92  depression categorized as: none to minimal (Patient Health Questionnaire score, 0-4), mild (5-9), or
93 logical Studies-Depression Scale, and 9-item Patient Health Questionnaire scores.
94 hological state was measured with the 9-item Patient Health Questionnaire, the PTSD Checklist-Militar
95                                   The 9-item Patient Health Questionnaire was used to assess depressi
96                  Depressive symptoms (9-item Patient Health Questionnaire) were assessed during index
97 e estimates ranged from 20.9% for the 9-item Patient Health Questionnaire with a cutoff of 10 or more
98 t-performing test for panic disorder was the Patient Health Questionnaire, with a positive likelihood
99 measured as a binary variable via the 9-item Patient Health Questionnaire, with a range of 0 (best) t

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。